What is Bom Bom?
Founded in 2017 and headquartered in Singapore, Bom Bom operates at the intersection of pet health and data science. The company specializes in NRC-compliant, on-demand meal formulations that cater to the specific physiological needs of pets, effectively removing the requirement for additional supplementation. With a primary footprint in Singapore and Korea, Bom Bom has successfully scaled its operations by addressing chronic health issues through precision nutrition. Its market position is defined by a commitment to high-quality standards and a scalable DTC infrastructure that facilitates rapid customer acquisition and retention in the pet care industry.
How much funding has Bom Bom raised?
Bom Bom has raised a total of $2.7M across 1 funding round:
Other Financing Round
$2.7M
Other Financing Round (2025): $2.7M with participation from Blueprint VC
Key Investors in Bom Bom
Blueprint VC
Blueprint Ventures is a venture capital firm focused on investing in next-generation consumer businesses in Southeast Asia, supporting founders who seek to differentiate their brands and compete globally.
What's next for Bom Bom?
With this major enterprise-level funding, Bom Bom is well-positioned to accelerate its regional expansion and enhance its proprietary nutritional algorithms. The capital will likely be deployed to optimize supply chain logistics and deepen market penetration in existing territories while exploring new demographics. As the pet tech landscape matures, Bom Bom's focus on data-backed health outcomes provides a distinct competitive advantage. Future strategic initiatives will likely center on product diversification and the integration of advanced health-tracking features, further cementing its role as a leader in the personalized pet nutrition space.
See full Bom Bom company page
